ENOS gene delivery prevents hypertension and reduces renal failure and injury in rats with reduced renal mass

Nephrology Dialysis Transplantation

Volumn 27, Issue 6, 2012, Pages 2182-2190

  Savard, Sébastien ^a   Lavoie, Philippe ^a   Villeneuve, Claude ^a   Agharazii, Mohsen ^a   Lebel, Marcel ^a   Larivire, Richard ^a  

^a Université Laval   (Canada)

Author keywords

Adenovirus; Endothelin 1; eNOS; Hypertension; Renal failure

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; CREATININE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; NITRATE; NITRIC OXIDE; NITRITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL MEDIA HYPERTROPHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; FOCAL GLOMERULOSCLEROSIS; HISTOPATHOLOGY; HYPERTENSION; KIDNEY CORTEX; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY INJURY; KIDNEY TUMOR; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; SYSTOLIC BLOOD PRESSURE; TUBULAR ATROPHY; URINARY EXCRETION; VIRAL GENE DELIVERY SYSTEM;

ACUTE KIDNEY INJURY; ADENOVIRIDAE; ANIMALS; BETA-GALACTOSIDASE; CATTLE; CELLS, CULTURED; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; HYPERTENSION; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PULMONARY ARTERY; RATS; RATS, SPRAGUE-DAWLEY; RENAL INSUFFICIENCY;

EID: 84861838891     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr641     Document Type: Article

References (53)

1. Morris ST, McMurray JJ, Spiers A et al. Impaired endothelial function in isolated human uremic resistance arteries. Kidney Int 2001; 60: 1077-1082
2. Lerman A, Sandok EK, Hilderbrand FL et al. Inhibition of endothelium-derived relaxing factor enhances endothelin-mediated vasoconstriction. Circulation 1992; 85: 1894-1898
3. Berthod H, Just A, Kirchhein H et al. Interaction between nitric oxide and endogenous vasoconstrictors in control of renal blood flow. Hypertension 1999; 34: 1254-1258
4. Katoh T, Takahashi K, Klahr S et al. Dietary supplementation with Larginine ameliorates glomerular hypertension in rats with subtotal nephrectomy. J Am Soc Nephrol 1994; 4: 1690-1694
5. Huang PL,Huang Z,MashimoHet al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995; 377: 239-242
6. Ribeiro MO, Antunes E, De Nucci G et al. Chronic inhibition of nitric oxide synthesis: a new model of arterial hypertension. Hypertension 1992; 20: 298-303
7. Baylis C, Mitruka B, Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest 1992; 90: 278-281
8. Therrien F, Lemieux P, Belanger S et al. Protective effects of angiotensin AT1 receptor blockade in malignant hypertension in the rat. Eur J Pharmacol 2009; 607: 126-134
9. Baylis C. Nitric oxide deficiency in chronic kidney disease. Am J Physiol Renal Physiol 2008; 294: F1-F9
10. Dumont Y, D'Amours M, Lebel M et al. Supplementation with a low dose of L-arginine reduces blood pressure and endothelin-1 production in hypertensive uraemic rats. Nephrol Dial Transplant 2001; 16: 746-754
11. Gao Y, Gumusel B, Koves G et al. Agmatine: a novel endogenous vasodilator substance. Life Sci 1995; 57: 83-86
12. Podjarny E, Benchetrit S, Rathaus M et al. Effect of tetrahydrobiopterin on blood pressure in rats after subtotal nephrectomy. Nephron Physiol 2003; 94: 6-9
13. Hasdan G, Benchetrit S, Rashid G et al. Endothelial dysfunction and hypertension in 5/6 nephrectomized rats are mediated by vascular superoxide. Kidney Int 2002; 61: 586-590
14. Vaziri ND, Oveisi F, Ding Y. Role of increased oxygen free radical activity in the pathogenesis of uremic hypertension. Kidney Int 1998; 53: 1748-1754
15. Vallance P, Leone A, Calver A et al. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992; 339: 572-575
16. Vaziri ND, Ni Z, Wang X et al. Downregulation of nitric oxide synthase in chronic renal insufficiency: role of excess PTH. Am J Physiol 1998; 274: F642-F649
17. Roczniak A, Frayer J, Levine D et al. Dowregulation of neuronal nitric oxide in the rat remnant kidney. J Am Soc Nephrol 1999; 10: 704-713
18. Aiello S, Noris M, Todeschini M et al. Renal and systemic nitric oxide synthesis in ratswith renalmass reduction. Kidney Int 1997; 52: 171-181
19. ScotlandRS,Morales-RuizM,ChenYet al. Functional reconstitution of endothelial nitric oxide synthase reveals the importance of serine 1179 in endothelium-dependent vasomotion. Circ Res 2002; 90: 904-910
20. Lee S, Trapnell B, Rade J et al. In vivo adenoviral vector-mediated gene transfer into balloon-injured rat carotid arteries. Circ Res 1993; 73: 797-807
21. Lavoie P, Robitaille G, Agharazii M et al. Neutralization of transforming growth factor-b attenuates hypertension and prevents renal injury in uremic rats. J Hypertens 2005; 23: 1895-1903
22. Just A, Olson AJ, Arendshorst WJ. Dual constrictor and dilator actions of ET(B) receptors in the rat renal microcirculation: interactions with ET(A) receptors. Am J Physiol Renal Physiol 2004; 286: F660-F668
23. Schulick AH, Dong G, Newman K et al. Endothelium-specific in vivo gene transfer. Circ Res 1995; 77: 475-485
24. Bourgoin F, Bachelard H, Badeau M et al. Endothelial and vascular dysfunction and insulin resistance in rats fed a high-fat, high-sucrose diet. Am J Physiol Heart Circ Physiol 2008; 295: H1044-H1055
25. D'Amours M, Chbinou N, Beaudoin J et al. Increased ET-1 and reduced ETB receptor expression in uremic hypertensive rats. Clin Exp Hypertens 2009; 32: 61-69
26. Larivière R, D'Amours M, Lebel M et al. Increased immunoreactive endothelin-1 levels in blood vessels and glomeruli of rats with reduced renal mass. Kidney Blood Press Res 1997; 20: 372-380
27. Larivière R, Lebel M, Kingma I et al. Effects of losartan and captopril on endothelin-1 production in blood vessels and glomeruli of rats with reduced renal mass. Am J Hypertens 1998; 11: 989-997
28. Wolf WC, Yoshida H, Agata J et al. Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure. Kidney Int 2000; 58: 730-739
29. Wang X, Cade R, Sun Z. Human eNOS gene delivery attenuates coldinduced elevation of blood pressure in rats. Am J Physiol Heart Circ Physiol 2005; 289: H1161-H1168
30. Smith RS Jr, Agata J, Xia CF et al. Human endothelial nitric oxide synthase gene delivery protects against cardiac remodeling and reduces oxidative stress after myocardial infarction. Life Sci 2005; 76: 2457-2471
31. Gava AL, Peotta VA, Cabral AM et al. Overexpression of eNOS prevents the development of renovascular hypertension in mice. Can J Physiol Pharmacol 2008; 86: 458-464
32. Lebel M, Rodrigue ME, AgharaziiMet al. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin. Am J Hypertens 2006; 19: 1286-1292
33. Guzman R, Lemarchand P, Crystal R et al. Efficient and selective adenovirus-mediated gene transfer into vascular neointima. Circulation 1993; 88: 2838-2848
34. Alexander MY, Brosnan MJ, Hamilton CA et al. Gene transfer of endothelial nitric oxide synthase improves nitric oxide-dependent endothelial function in a hypertensive rat model. Cardiovasc Res 1999; 43: 798-807
35. Nakane H, Miller FJ Jr., Faraci FM et al. Gene transfer of endothelial nitric oxide synthase reduces angiotensin II-induced endothelial dysfunction. Hypertension 2000; 35: 595-601
36. Lake-Bruse KD, Faraci FM, Shesely EG et al. Gene transfer of endothelial nitric oxide synthase (eNOS) in eNOS-deficient mice. Am J Physiol 1999; 277: H770-H7706
37. Brochu E, Lacasse MS, Moreau C et al. Endothelin ETA receptor blockade prevents the progression of renal failure and hypertension in uremic rats. Nephrol Dial Transplant 1999; 14: 1881-1888
38. Dumont Y, D'Amours M, Lebel M et al. Blood pressure-independent effects of angiotensin AT1 receptor blockade on renal endothelin-1 production in hypertensive uremic rats. J Hypertens 2001; 19: 1479-1487
39. Zhou MS, Schulman IH, Raij L. Nitric oxide, angiotensin II, and hypertension. Semin Nephrol 2004; 24: 366-378
40. De Nucci G, Thomas R, D'Orléans-Juste P et al. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endotheliumderived relaxing factor. Proc Natl Acad Sci USA 1988; 85: 9797-9800
41. Bruzzi I, Benigni A, Remuzzi G. Role of increased glomerular protein traffic in the progression of renal failure. Kidney Int 1997; 62: S29-S31
42. Granger JP, Alberola AM, Salazar FJ et al. Control of renal hemodynamics during intrarenal and systemic blockade of nitric oxide synthesis in conscious dogs. J Cardiovasc Pharmacol 1992; 20: S160-S162
43. Lahera V, Salon MG, Miranda-Guardiola F et al. Effects of NG-nitro-L-arginine methyl ester on renal function and blood pressure. Am J Physiol 1991; 261: F1033-F1037
44. Lahera V, Navarro-Cid J, Cachofeiro V et al. Nitric oxide, the kidney, and hypertension. Am J Hypertens 1997; 10: 129-140
45. Deng A, Baylis C. Locally produced EDRF control preglomerular resistance and ultrafiltration coefficient. Am J Physiol 1993; 264: F212-F215
46. Ito S, Johnson CS, Carretero OA. Modulation of angiotensin II-induced vasoconstriction by endothelium-derived relaxing factor in the isolated microperfused rabbit afferent arteriole. J Clin Invest 1991; 87: 1656-1663
47. Ito S, Juncos LA, Nushiro N et al. Endothelium-derived relaxing factor modulates endothelin action in afferent arterioles. Hypertension 1991; 17: 1052-1056
48. Mattson DL, Roman RJ, Cowley AWJ. Role of nitric oxide in renal papillary blood flow and sodium excretion. Hypertension 1992; 19: 766-769
49. Boulanger C, Lüscher TF. Release of endothelin from the porcine aorta: inhibition by endothelium-derived nitric oxide. J Clin Invest 1990; 85: 587-590
50. Mattana J, Singhal PC. L-arginine supplementation antagonizes the effects of angiotensin II and endothelin 1 on mesangial cell proliferation. Cell Physiol Biochem 1995; 5: 176-192
51. Trachtman H, Futterweit S, Singhal P. Nitric oxide modulates the synthesis of extracellular matrix proteins in cultured rat mesangial cells. Biochem Biophys Res Commun 1995; 207: 120-125
52. Tiefenbacher CP. Tetrahydrobiopterin: a critical cofactor for eNOS and a strategy in the treatment of endothelial dysfunction? Am J Physiol Heart Circ Physiol 2001; 280: H2484-H2488
53. Griendling K, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 2000; 86: 494-501